Trial Profile
Effect of Liraglutide and Exenatide in patients with type 2 diabetes mellitus, on circulating endothelial progenitor cells (EPCs) and capillary density
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Sep 2018
Price :
$35
*
At a glance
- Drugs Exenatide (Primary) ; Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 20 Sep 2018 New trial record
- 10 Sep 2018 Results published in the High Blood Pressure and Cardiovascular Prevention